Celltrion considering up to $50 million buyback of 2.75% convertibles

By Marisa Wong

Madison, Wis., April 19 - Celltrion, Inc. said it plans to spend up to $50 million in cash to repurchase some of its $300 million 2.75% convertible bonds due 2018.

The company said it plans to complete the repurchase as soon as possible but is still working out the details of the buyback, including the amount, method and price.

Celltrion is a biopharmaceutical company based in Incheon, South Korea.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.